Filed 2mo ago· Mar 16, 2026
40 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
Merck
MRK
$1K-$15K
+0.8% vs S&P 500
Trade dateFeb 4, 2026
Stock
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 111
Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Stock
Filed 4mo ago· Jan 12, 2026
24 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+16.5% vs S&P 500
Trade dateDec 19, 2025
Stock
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+20.4% vs S&P 500
Trade dateNov 18, 2025
Stock
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Stock
Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
Merck
MRK
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Stock
Filed 8mo ago· Oct 5, 2025
200 days to disclose · 155 past 45-day window
Sheri Biggs
RHouseSouth Carolina-03
↓sold
Merck
MRK
$15K-$50K
+1.1% vs S&P 500
Trade dateMar 19, 2025
Stock
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
38 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+28.5% vs S&P 500
Trade dateAug 5, 2025
Stock
Filed 8mo ago· Sep 12, 2025
39 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
Merck
MRK
$1K-$15K
+11.7% vs S&P 500
Trade dateAug 4, 2025
Stock
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Merck
MRK
$1K-$15K
+12.2% vs S&P 500
Trade dateOct 29, 2024
Stock
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Merck
MRK
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Stock
Filed 9mo ago· Aug 29, 2025
1 day to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Merck
MRK
$1K-$15K
+27.6% vs S&P 500
Trade dateAug 28, 2025
Stock
Filed 9mo ago· Aug 20, 2025
40 days to disclose
Ritchie Torres
DHouseNew York-15
↓sold
Merck
MRK
$1K-$15K
+9.9% vs S&P 500
Trade dateJul 11, 2025
Stock
Filed 9mo ago· Aug 20, 2025
328 days to disclose · 283 past 45-day windowRitchie Torres
DHouseNew York-15
↑bought
Merck
MRK
$1K-$15K
−25.8% vs S&P 500
Trade dateSep 26, 2024
Stock
Filed 9mo ago· Aug 13, 2025
50 days to disclose · 5 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Merck
MRK
$1K-$15K
+30.4% vs S&P 500
Trade dateJun 24, 2025
Stock
⚑ Pharmaceutical
Filed 10mo ago· Jul 14, 2025
28 days to disclose
Scott Franklin
RHouseFlorida-18
↓sold
Merck
MRK
$1K-$15K
+9.4% vs S&P 500
Trade dateJun 16, 2025
Stock
Filed 10mo ago· Jul 14, 2025
31 days to discloseJulie Johnson
DHouseTexas-32
↑bought
Merck
MRK
$1K-$15K
+29.9% vs S&P 500
Trade dateJun 13, 2025
Stock
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Merck
MRK
$1K-$15K
−0.8% vs S&P 500
Trade dateAug 7, 2024
Stock
Filed 12mo ago· Jun 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Merck
MRK
$1K-$15K
+12.0% vs S&P 500
Trade dateMay 30, 2025
Stock
Filed 1.0y ago· May 31, 2025
16 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Merck
MRK
$15K-$50K
+13.8% vs S&P 500
Trade dateMay 15, 2025
Stock
⚑ Pharmaceutical
Filed 1.1y ago· May 12, 2025
21 days to disclose
Bruce Westerman
RHouseArkansas-04
↓sold
Merck
MRK
$1K-$15K
+12.0% vs S&P 500
Trade dateApr 21, 2025
Stock
Filed 1.1y ago· May 8, 2025
21 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Merck
MRK
$15K-$50K
+9.6% vs S&P 500
Trade dateApr 17, 2025
Stock
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Merck
MRK
$15K-$50K
+32.2% vs S&P 500
Trade dateApr 8, 2025
Stock
⚑ Pharmaceutical
Filed 1.1y ago· May 6, 2025
1 day to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Merck
MRK
$1K-$15K
+29.6% vs S&P 500
Trade dateMay 5, 2025
Stock
Filed 1.1y ago· May 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+27.4% vs S&P 500
Trade dateApr 29, 2025
Stock
Filed 1.1y ago· Apr 16, 2025
44 days to discloseBruce Westerman
RHouseArkansas-04
↑bought
Merck
MRK
$1K-$15K
+22.6% vs S&P 500
Trade dateMar 3, 2025
Stock
Filed 1.1y ago· Apr 11, 2025
2 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Merck
MRK
$1K-$15K
+31.6% vs S&P 500
Trade dateApr 9, 2025
Stock
Filed 1.1y ago· Apr 11, 2025
22 days to disclose
Kelly Morrison
DHouseMinnesota-03
↓sold
Merck
MRK
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 20, 2025
Stock
⚑ Pharmaceutical
Filed 1.2y ago· Apr 7, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Merck
MRK
$15K-$50K
+1.7% vs S&P 500
Trade dateMar 31, 2025
Stock
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Merck
MRK
$15K-$50K
Trade dateFeb 25, 2025
Stock
⚑ Pharmaceutical
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Merck
MRK
$15K-$50K
+23.8% vs S&P 500
Trade dateFeb 24, 2025
Stock
Filed 1.2y ago· Mar 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$15K-$50K
+26.6% vs S&P 500
Trade dateFeb 26, 2025
Stock
Filed 1.3y ago· Feb 12, 2025
26 days to discloseJulie Johnson
DHouseTexas-32
↑bought
Merck
MRK
$1K-$15K
+10.0% vs S&P 500
Trade dateJan 17, 2025
Stock
Filed 1.3y ago· Feb 11, 2025
18 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Merck
MRK
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
14 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Merck
MRK
$15K-$50K
+0.7% vs S&P 500
Trade dateJan 27, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
25 days to disclose
Byron Donalds
RHouseFlorida-19
↓sold
Merck
MRK
$1K-$15K
+5.2% vs S&P 500
Trade dateJan 16, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
25 days to discloseByron Donalds
RHouseFlorida-19
↓sold
Merck
MRK
$1K-$15K
+5.2% vs S&P 500
Trade dateJan 16, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
26 days to disclose
Jared Moskowitz
DHouseFlorida-23
↑bought
Merck
MRK
$1K-$15K
+7.8% vs S&P 500
Trade dateJan 15, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
26 days to discloseJared Moskowitz
DHouseFlorida-23
↓sold
Merck
MRK
$1K-$15K
+5.6% vs S&P 500
Trade dateJan 15, 2025
Stock
Filed 1.3y ago· Feb 10, 2025
26 days to discloseJared Moskowitz
DHouseFlorida-23
↓sold
Merck
MRK
$1K-$15K
+5.6% vs S&P 500
Trade dateJan 15, 2025
Stock
Filed 1.5y ago· Dec 9, 2024
31 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Merck
MRK
$1K-$15K
+11.5% vs S&P 500
Trade dateNov 8, 2024
Stock
Filed 1.6y ago· Oct 11, 2024
17 days to disclose
Jonathan L. Jackson
DHouseIllinois-01
↓sold
Merck
MRK
$15K-$50K
+24.9% vs S&P 500
Trade dateSep 24, 2024
Stock
Filed 1.7y ago· Sep 6, 2024
2 days to disclose
John James
RHouseMichigan-10
↓sold
Merck
MRK
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
Stock
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Merck
MRK
$1K-$15K
−5.6% vs S&P 500
Trade dateNov 10, 2023
Stock
⚑ Pharmaceutical
Filed 1.8y ago· Aug 21, 2024
355 days to disclose · 310 past 45-day windowJared Moskowitz
DHouseFlorida-23
↑bought
Merck
MRK
$1K-$15K
−5.6% vs S&P 500
Trade dateSep 1, 2023
Stock
Filed 1.8y ago· Aug 21, 2024
404 days to disclose · 359 past 45-day windowJared Moskowitz
DHouseFlorida-23
↑bought
Merck
MRK
$1K-$15K
−7.0% vs S&P 500
Trade dateJul 14, 2023
Stock
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Merck
MRK
$1K-$15K
Trade dateAug 2, 2024
Stock
Filed 1.8y ago· Aug 16, 2024
45 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
−13.9% vs S&P 500
Trade dateJul 2, 2024
Stock
Filed 1.9y ago· Jul 9, 2024
18 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Merck
MRK
$1K-$15K
+1.2% vs S&P 500
Trade dateJun 21, 2024
Stock
Filed 2.1y ago· May 2, 2024
22 days to disclose
Michael C. Burgess
—HouseTexas-26
↓sold
Merck
MRK
$1K-$15K
+50.6% vs S&P 500
Trade dateApr 10, 2024
Stock
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
−11.3% vs S&P 500
Trade dateJan 23, 2024
Stock
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
−11.3% vs S&P 500
Trade dateJan 23, 2024
Stock
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$15K-$50K
−11.3% vs S&P 500
Trade dateJan 23, 2024
Stock
Filed 2.4y ago· Jan 22, 2024
25 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Merck
MRK
$1K-$15K
−4.6% vs S&P 500
Trade dateDec 28, 2023
Stock
Filed 2.4y ago· Jan 22, 2024
25 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Merck
MRK
$1K-$15K
−4.6% vs S&P 500
Trade dateDec 28, 2023
Stock
Filed 2.5y ago· Nov 16, 2023
31 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Merck
MRK
$1K-$15K
+13.2% vs S&P 500
Trade dateOct 16, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 9, 2023
16 days to disclose
Greg Stanton
DHouseArizona-04
↓sold
Merck
MRK
$1K-$15K
+16.3% vs S&P 500
Trade dateOct 24, 2023
Stock
Filed 2.6y ago· Nov 9, 2023
44 days to discloseGreg Stanton
DHouseArizona-04
↑bought
Merck
MRK
$1K-$15K
−6.7% vs S&P 500
Trade dateSep 26, 2023
Stock
Filed 2.6y ago· Oct 20, 2023
29 days to disclose
Pete Ricketts
RSenateNebraska
↓sold
Merck
MRK
$50K-$100K
+13.9% vs S&P 500
Trade dateSep 21, 2023
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Merck
MRK
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
Stock
Filed 2.6y ago· Oct 10, 2023
32 days to disclose
Lois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Stock
Filed 2.6y ago· Oct 10, 2023
34 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+13.0% vs S&P 500
Trade dateSep 6, 2023
Stock
Filed 2.7y ago· Oct 3, 2023
20 days to discloseMichael C. Burgess
—HouseTexas-26
↓sold
Merck
MRK
$1K-$15K
+11.8% vs S&P 500
Trade dateSep 13, 2023
Stock
Filed 2.8y ago· Aug 26, 2023
24 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+11.2% vs S&P 500
Trade dateAug 2, 2023
Stock
Filed 2.8y ago· Aug 13, 2023
30 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Merck
MRK
$1K-$15K
+12.8% vs S&P 500
Trade dateJul 14, 2023
Stock
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Merck
MRK
$1K-$15K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Stock
Filed 2.8y ago· Aug 10, 2023
883 days to disclose · 838 past 45-day window
Rick W. Allen
RHouseGeorgia-12
↓sold
Merck
MRK
$15K-$50K
Trade dateMar 10, 2021
Stock
⚑ Pharmaceutical
Filed 2.8y ago· Aug 10, 2023
1134 days to disclose · 1089 past 45-day windowRick W. Allen
RHouseGeorgia-12
↑bought
Merck
MRK
$15K-$50K
Trade dateJul 2, 2020
Stock
⚑ Pharmaceutical
Filed 2.8y ago· Aug 10, 2023
2079 days to disclose · 2034 past 45-day windowRick W. Allen
RHouseGeorgia-12
↓sold
Merck
MRK
$1K-$15K
Trade dateNov 30, 2017
Stock
⚑ Pharmaceutical
Filed 2.9y ago· Jul 28, 2023
30 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+13.8% vs S&P 500
Trade dateJun 28, 2023
Stock
Filed 3.0y ago· Jun 6, 2023
12 days to disclose
Zoe Lofgren
DHouseCalifornia-18
↓sold
Merck
MRK
$1K-$15K
+16.2% vs S&P 500
Trade dateMay 25, 2023
Stock
Filed 3.0y ago· May 26, 2023
323 days to disclose · 278 past 45-day window
Rick Larsen
DHouseWashington-02
↑bought
Merck
MRK
$1K-$15K
+7.0% vs S&P 500
Trade dateJul 7, 2022
Stock
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Merck
MRK
$1K-$15K
−10.5% vs S&P 500
Trade dateApr 10, 2023
Stock
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Merck
MRK
$15K-$50K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Stock
Filed 3.2y ago· Mar 10, 2023
14 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Merck
MRK
$1K-$15K
−12.2% vs S&P 500
Trade dateFeb 24, 2023
Stock
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Merck
MRK
$1K-$15K
−5.6% vs S&P 500
Trade dateJan 31, 2023
Stock
Filed 3.3y ago· Feb 17, 2023
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Merck
MRK
$1K-$15K
+9.8% vs S&P 500
Trade dateJan 11, 2023
Stock
Filed 3.5y ago· Dec 19, 2022
1159 days to disclose · 1114 past 45-day window
Thomas R. Suozzi
DHouseNew York-03
↓sold
Merck
MRK
$15K-$50K
Trade dateOct 17, 2019
Stock
⚑ Pharmaceutical
Filed 3.6y ago· Oct 11, 2022
29 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
+15.8% vs S&P 500
Trade dateSep 12, 2022
Stock
Filed 3.7y ago· Oct 5, 2022
20 days to disclose
Earl Blumenauer
—HouseOregon-03
↓sold
Merck
MRK
$15K-$50K
+16.2% vs S&P 500
Trade dateSep 15, 2022
Filed 3.7y ago· Sep 14, 2022
40 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Merck
MRK
$1K-$15K
+13.0% vs S&P 500
Trade dateAug 5, 2022
Stock
Filed 3.8y ago· Sep 2, 2022
401 days to disclose · 356 past 45-day window
Carol D. Miller
RHouseWest Virginia-01
↓sold
Merck
MRK
$15K-$50K
+19.8% vs S&P 500
Trade dateJul 28, 2021
Stock
⚑ Pharmaceutical
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Merck
MRK
$1K-$15K
+5.5% vs S&P 500
Trade dateJul 15, 2022
Stock
Filed 4.0y ago· Jun 16, 2022
15 days to discloseLois Frankel
DHouseFlorida-22
↓sold
Merck
MRK
$1K-$15K
+13.9% vs S&P 500
Trade dateJun 1, 2022
Stock
Filed 4.1y ago· Apr 19, 2022
34 days to disclose
John H. Rutherford
RHouseFlorida-05
↓sold
Merck
MRK
$1K-$15K
+10.8% vs S&P 500
Trade dateMar 16, 2022
Stock
Filed 4.2y ago· Apr 8, 2022
9 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Merck
MRK
$1K-$15K
−19.8% vs S&P 500
Trade dateMar 30, 2022
⚑ Pharmaceutical
Filed 4.2y ago· Mar 9, 2022
9 days to disclose
Robert J. Wittman
RHouseVirginia-01
↓sold
Merck
MRK
$1K-$15K
+14.3% vs S&P 500
Trade dateFeb 28, 2022
Stock
Filed 4.4y ago· Jan 16, 2022
44 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Merck
MRK
$1K-$15K
+40.9% vs S&P 500
Trade dateDec 3, 2021
Stock
Filed 4.5y ago· Nov 28, 2021
2 days to disclose
Bob Gibbs
—HouseOhio-07
↑bought
Merck
MRK
$1K-$15K
+41.2% vs S&P 500
Trade dateNov 26, 2021
Stock
Filed 4.6y ago· Oct 14, 2021
28 days to disclose
Katherine M. Clark
DHouseMassachusetts-05
↓sold
Merck
MRK
$1K-$15K
+59.6% vs S&P 500
Trade dateSep 16, 2021
Stock
Filed 4.7y ago· Oct 7, 2021
7 days to discloseZoe Lofgren
DHouseCalifornia-18
↑bought
Merck
MRK
$1K-$15K
+34.5% vs S&P 500
Trade dateSep 30, 2021
Stock
Filed 4.7y ago· Sep 23, 2021
675 days to disclose · 630 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Merck
MRK
$15K-$50K
Trade dateNov 18, 2019
Stock
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
1498 days to disclose · 1453 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↑bought
Merck
MRK
$15K-$50K
Trade dateAug 17, 2017
Stock
⚑ Pharmaceutical
Filed 4.8y ago· Sep 1, 2021
9 days to disclose
Thomas R Carper
DSenateDelaware
↓sold
Landmark Infrastructure Partners LP
LMRK
$1K-$15K
Trade dateAug 23, 2021
Filed 4.8y ago· Aug 26, 2021
365 days to disclose · 320 past 45-day window
Tom Malinowski
—HouseNew Jersey-07
↑bought
Merck
MRK
$15K-$50K
Trade dateAug 26, 2020
Common Stock
Filed 4.8y ago· Aug 15, 2021
19 days to discloseKatherine M. Clark
DHouseMassachusetts-05
↑bought
Merck
MRK
$1K-$15K
−18.2% vs S&P 500
Trade dateJul 27, 2021
Stock
Filed 4.8y ago· Aug 15, 2021
19 days to discloseKatherine M. Clark
DHouseMassachusetts-05
↑bought
Merck
MRK
$1K-$15K
−18.2% vs S&P 500
Trade dateJul 27, 2021
Stock
Filed 4.8y ago· Aug 6, 2021
18 days to disclose
John R. Curtis
RSenateUtah
↓sold
Merck
MRK
$1K-$15K
+22.8% vs S&P 500
Trade dateJul 19, 2021
Stock
⚑ Pharmaceutical
Filed 4.9y ago· Jul 23, 2021
116 days to disclose · 71 past 45-day windowTommy Tuberville
RSenateAlabama
↓sold
Merck
MRK
$1K-$15K
Trade dateMar 29, 2021
⚑ Pharmaceutical
Filed 4.9y ago· Jul 9, 2021
37 days to disclose
John W. Hickenlooper
DSenateColorado
↔exchanged
Merck
MRK
$1K-$15K
Trade dateJun 2, 2021
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Mar 16, 2026 2mo ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Merck MRK Stock | Feb 4, 2026 40 days to disclose | Bad buy·−$323-4.0% +0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Dec 19, 2025 24 days to disclose | Good buy·+$987+12.3% +16.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Nov 18, 2025 27 days to disclose | Good buy·+$1.4K+17.8% +20.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Merck MRK Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2025 8mo ago | Sheri Biggs RHouseSouth Carolina-03 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Research and Technology | Mar 19, 2025 200 days to disclose · 155 past 45-day window | Flat·+0.0% +1.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Aug 5, 2025 38 days to disclose | Good buy·+$3.2K+40.6% +28.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Merck MRK Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$980+12.2% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Merck MRK Stock | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 29, 2025 9mo ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | Aug 28, 2025 1 day to disclose | Good buy·+$2.9K+36.5% +27.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↓sold | Merck MRK Stock | Jul 11, 2025 40 days to disclose | Flat·+0.0% +9.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↑bought | Merck MRK Stock | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Bad buy·−$84-1.1% −25.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 50 days to disclose · 5 past 45-day window | Good buy·+$3.3K+41.4% +30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | Scott Franklin RHouseFlorida-18 | ↓sold | Merck MRK Stock | Jun 16, 2025 28 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | Julie Johnson DHouseTexas-32 | ↑bought | Merck MRK Stock | Jun 13, 2025 31 days to disclose | Good buy·+$3.1K+39.0% +29.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Merck MRK Stock | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$76+1.0% −0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Merck MRK Stock | May 30, 2025 7 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 12, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↓sold | Merck MRK Stock | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Merck MRK Stock | Apr 17, 2025 21 days to disclose | Flat·+0.0% +9.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Good buy·+$14.2K+43.8% +32.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | May 5, 2025 1 day to disclose | Good buy·+$3K+37.1% +29.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Apr 29, 2025 7 days to disclose | Good buy·+$2.7K+34.1% +27.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↑bought | Merck MRK Stock | Mar 3, 2025 44 days to disclose | Good buy·+$1.8K+21.9% +22.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | Apr 9, 2025 2 days to disclose | Good buy·+$3.1K+38.6% +31.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Kelly Morrison DHouseMinnesota-03 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Health | Mar 20, 2025 22 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Merck MRK Stock | Mar 31, 2025 7 days to disclose | Flat·+0.0% +1.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Merck MRK Stock | Feb 24, 2025 13 days to disclose | Good buy·+$7.9K+24.4% +23.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 6, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Feb 26, 2025 8 days to disclose | Good buy·+$8.8K+27.1% +26.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↑bought | Merck MRK Stock | Jan 17, 2025 26 days to disclose | Good buy·+$1.3K+16.0% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Merck MRK Stock | Jan 24, 2025 18 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Merck MRK Stock | Jan 27, 2025 14 days to disclose | Flat·+0.0% +0.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 10, 2025 1.3y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Merck MRK Stock | Jan 16, 2025 25 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Byron Donalds RHouseFlorida-19 | ↓sold | Merck MRK Stock | Jan 16, 2025 25 days to disclose | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Jan 15, 2025 26 days to disclose | Good buy·+$1.1K+13.5% +7.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Merck MRK Stock | Jan 15, 2025 26 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Merck MRK Stock | Jan 15, 2025 26 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2024 1.5y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Nov 8, 2024 31 days to disclose | Good buy·+$827+10.3% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 11, 2024 1.6y ago | Jonathan L. Jackson DHouseIllinois-01 | ↓sold | Merck MRK Stock | Sep 24, 2024 17 days to disclose | Flat·+0.0% +24.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$960+12.0% −5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Sep 1, 2023 355 days to disclose · 310 past 45-day window | Good buy·+$450+5.6% −5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Jul 14, 2023 404 days to disclose · 359 past 45-day window | Good buy·+$464+5.8% −7.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Merck MRK Stock | Aug 2, 2024 18 days to disclose | Bad buy·−$114-1.4% | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jul 2, 2024 45 days to disclose | Bad buy·−$887-11.1% −13.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 9, 2024 1.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Merck MRK Stock | Jun 21, 2024 18 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2024 2.1y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Merck MRK Stock | Apr 10, 2024 22 days to disclose | Smart sell·+$937+11.7% +50.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jan 23, 2024 14 days to disclose | Bad buy·−$419-5.2% −11.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jan 23, 2024 14 days to disclose | Bad buy·−$419-5.2% −11.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jan 23, 2024 14 days to disclose | Bad buy·−$1.7K-5.2% −11.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 22, 2024 2.4y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Dec 28, 2023 25 days to disclose | Good buy·+$352+4.4% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Dec 28, 2023 25 days to disclose | Good buy·+$352+4.4% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | Merck MRK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Flat·+0.0% +13.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 9, 2023 2.6y ago | Greg Stanton DHouseArizona-04 | ↓sold | Merck MRK Stock | Oct 24, 2023 16 days to disclose | Flat·+0.0% +16.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 9, 2023 2.6y ago | Greg Stanton DHouseArizona-04 | ↑bought | Merck MRK Stock | Sep 26, 2023 44 days to disclose | Good buy·+$620+7.8% −6.7% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 20, 2023 2.6y ago | Pete Ricketts RSenateNebraska | ↓sold | Merck MRK | Sep 21, 2023 29 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $50K-$100K midpoint $75K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Merck MRK Stock | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Sep 6, 2023 34 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2023 2.7y ago | Michael C. Burgess —HouseTexas-26 | ↓sold | Merck MRK Stock | Sep 13, 2023 20 days to disclose | Flat·+0.0% +11.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 26, 2023 2.8y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Aug 2, 2023 24 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Merck MRK Stock | Jul 14, 2023 30 days to disclose | Flat·+0.0% +12.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Merck MRK Stock | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Mar 10, 2021 883 days to disclose · 838 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 2, 2020 1134 days to disclose · 1089 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Nov 30, 2017 2079 days to disclose · 2034 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 28, 2023 2.9y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Jun 28, 2023 30 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2023 3.0y ago | Zoe Lofgren DHouseCalifornia-18 | ↓sold | Merck MRK Stock | May 25, 2023 12 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 26, 2023 3.0y ago | Rick Larsen DHouseWashington-02 | ↑bought | Merck MRK Stock | Jul 7, 2022 323 days to disclose · 278 past 45-day window | Good buy·+$1.7K+21.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Merck MRK Stock | Apr 10, 2023 39 days to disclose | Good buy·+$67+0.8% −10.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Merck MRK Stock | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 10, 2023 3.2y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Feb 24, 2023 14 days to disclose | Good buy·+$267+3.3% −12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Merck MRK Stock | Jan 31, 2023 24 days to disclose | Good buy·+$458+5.7% −5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 17, 2023 3.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Merck MRK Stock | Jan 11, 2023 37 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Oct 17, 2019 1159 days to disclose · 1114 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Oct 11, 2022 3.6y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Sep 12, 2022 29 days to disclose | Good buy·+$2.3K+28.8% +15.8% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2022 3.7y ago | Earl Blumenauer —HouseOregon-03 | ↓sold | Merck MRK | Sep 15, 2022 20 days to disclose | Flat·+0.0% +16.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Merck MRK Stock | Aug 5, 2022 40 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Jul 28, 2021 401 days to disclose · 356 past 45-day window | Missed gain·−$13.9K-42.9% +19.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Merck MRK Stock | Jul 15, 2022 26 days to disclose | Good buy·+$1.6K+19.6% +5.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 16, 2022 4.0y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Jun 1, 2022 15 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 19, 2022 4.1y ago | John H. Rutherford RHouseFlorida-05 | ↓sold | Merck MRK Stock | Mar 16, 2022 34 days to disclose | Flat·+0.0% +10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2022 4.2y ago | Tommy Tuberville RSenateAlabama | ↑bought | Merck MRK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 30, 2022 9 days to disclose | Good buy·+$2.9K+35.8% −19.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2022 4.2y ago | Robert J. Wittman RHouseVirginia-01 | ↓sold | Merck MRK Stock | Feb 28, 2022 9 days to disclose | Flat·+0.0% +14.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 16, 2022 4.4y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Merck MRK Stock | Dec 3, 2021 44 days to disclose | Good buy·+$4.4K+54.8% +40.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 28, 2021 4.5y ago | Bob Gibbs —HouseOhio-07 | ↑bought | Merck MRK Stock | Nov 26, 2021 2 days to disclose | Good buy·+$4.3K+53.7% +41.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 14, 2021 4.6y ago | Katherine M. Clark DHouseMassachusetts-05 | ↓sold | Merck MRK Stock | Sep 16, 2021 28 days to disclose | Flat·+0.0% +59.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 7, 2021 4.7y ago | Zoe Lofgren DHouseCalifornia-18 | ↑bought | Merck MRK Stock | Sep 30, 2021 7 days to disclose | Good buy·+$4.1K+51.2% +34.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Nov 18, 2019 675 days to disclose · 630 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Ways and Means | Aug 17, 2017 1498 days to disclose · 1453 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 1, 2021 4.8y ago | Thomas R Carper DSenateDelaware | ↓sold | Landmark Infrastructure Partners LP LMRK | Aug 23, 2021 9 days to disclose | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | Tom Malinowski —HouseNew Jersey-07 | ↑bought | Merck MRK Common Stock | Aug 26, 2020 365 days to disclose · 320 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Aug 15, 2021 4.8y ago | Katherine M. Clark DHouseMassachusetts-05 | ↑bought | Merck MRK Stock | Jul 27, 2021 19 days to disclose | Good buy·+$3.5K+44.3% −18.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2021 4.8y ago | Katherine M. Clark DHouseMassachusetts-05 | ↑bought | Merck MRK Stock | Jul 27, 2021 19 days to disclose | Good buy·+$3.5K+44.3% −18.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 6, 2021 4.8y ago | John R. Curtis RSenateUtah | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jul 19, 2021 18 days to disclose | Missed gain·−$3.6K-45.2% +22.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 23, 2021 4.9y ago | Tommy Tuberville RSenateAlabama | ↓sold | Merck MRK ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 29, 2021 116 days to disclose · 71 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 9, 2021 4.9y ago | John W. Hickenlooper DSenateColorado | ↔exchanged | Merck MRK ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jun 2, 2021 37 days to disclose | price pending | $1K-$15K midpoint $8K |